• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.美国胃肠病学会中重度管腔及肛周瘘管型克罗恩病医学管理临床实践指南
Gastroenterology. 2021 Jun;160(7):2496-2508. doi: 10.1053/j.gastro.2021.04.022.
2
Providing the Best Care for Patients With Crohn's Disease: An Examination of the New AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.为克罗恩病患者提供最佳护理：对美国胃肠病学会关于中度至重度肠腔和肛周瘘管性克罗恩病药物治疗的新临床实践指南的审视。
Gastroenterology. 2021 Jun;160(7):2557-2562. doi: 10.1053/j.gastro.2021.04.024.
3
Spotlight: Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.聚焦：中度至重度管腔型和肛周瘘管性克罗恩病的医学管理
Gastroenterology. 2021 Jun;160(7):2511. doi: 10.1053/j.gastro.2021.04.028. Epub 2021 Apr 21.
4
AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.AGA 技术评论：中重度肠腔和肛旁瘘管型克罗恩病的医学管理
Gastroenterology. 2021 Jun;160(7):2512-2556.e9. doi: 10.1053/j.gastro.2021.04.023.
5
Management of Perianal Fistulizing Crohn's Disease.肛周克罗恩病瘘管的管理。
Inflamm Bowel Dis. 2024 Sep 3;30(9):1579-1603. doi: 10.1093/ibd/izad195.
6
Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.肛周瘘管性克罗恩病：发病机制、诊断与治疗。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):652-664. doi: 10.1038/nrgastro.2017.104. Epub 2017 Aug 9.
7
[Management of perianal fistulizing Crohn's disease: a conservative approach].[肛周瘘管性克罗恩病的管理：一种保守方法]
Dtsch Med Wochenschr. 2005 Aug 26;130(34-35):1968. doi: 10.1055/s-2005-872612.
8
Recurrent Pediatric Perianal Swelling.复发性小儿肛周肿胀
Pediatr Ann. 2016 Feb;45(2):e59-62. doi: 10.3928/00904481-20160113-02.
9
Interdisciplinary Management of Perianal Crohn's Disease.肛周克罗恩病的多学科管理。
Gastroenterol Clin North Am. 2017 Sep;46(3):547-562. doi: 10.1016/j.gtc.2017.05.008.
10
Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells.富含脂肪来源再生细胞的自体微脂肪治疗肛周瘘管型克罗恩病
Inflamm Bowel Dis. 2022 Jun 3;28(6):967-970. doi: 10.1093/ibd/izab276.

引用本文的文献

1
Self-Injection Satisfaction and Safety of CT-P17 (Yuflyma), a High-Concentration Adalimumab Biosimilar, in Patients With Crohn's Disease: A Cross-Sectional Study.高浓度阿达木单抗生物类似药CT-P17（Yuflyma）在克罗恩病患者中的自我注射满意度及安全性：一项横断面研究
JGH Open. 2025 Jul 28;9(8):e70230. doi: 10.1002/jgh3.70230. eCollection 2025 Aug.
2
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS study.英国炎症性肠病注册中心关于克罗恩病抗TNF治疗后二线生物治疗的真实世界结果：BISCUITS研究结果
Therap Adv Gastroenterol. 2025 Jul 28;18:17562848251352446. doi: 10.1177/17562848251352446. eCollection 2025.
3
Diagnosis and treatment for anal fistula: a systematic review of clinical practice guidelines and consensus statements.肛瘘的诊断与治疗：临床实践指南与共识声明的系统评价
Front Surg. 2025 Jul 2;12:1566130. doi: 10.3389/fsurg.2025.1566130. eCollection 2025.
4
Anti-IL 12/23 versus Anti-Tumor Necrosis Factor-α in Patients with Biologically Naïve Crohn's Disease: A Systematic Review and Meta-analysis.初治克罗恩病患者中抗白细胞介素12/23与抗肿瘤坏死因子-α的比较：一项系统评价和荟萃分析
Inflamm Intest Dis. 2025 Jun 10;10(1):169-179. doi: 10.1159/000546858. eCollection 2025 Jan-Dec.
5
Exposure to advanced therapies and risk of surgery in Crohn's disease.克罗恩病患者接受先进疗法与手术风险
Surg Endosc. 2025 Jul 7. doi: 10.1007/s00464-025-11919-7.
6
A Guide Through the Tunnel: Updates in the Approach to Classification and Management of Perianal Fistulizing Crohn's Disease.《穿越隧道指南：肛周瘘管型克罗恩病分类与管理方法的更新》
Curr Gastroenterol Rep. 2025 Jun 27;27(1):46. doi: 10.1007/s11894-025-00998-0.
7
Epidemiology and Steroid Dependency Reduction in Crohn's Disease During the Biologics Era: A Nationwide Population-Based Study.生物制剂时代克罗恩病的流行病学及类固醇依赖减少：一项基于全国人口的研究
Adv Ther. 2025 Jun 23. doi: 10.1007/s12325-025-03245-0.
8
A Guide to the Patient-Centric Use of Vedolizumab for Crohn's Disease.维多珠单抗以患者为中心治疗克罗恩病指南
Inflamm Bowel Dis. 2025 Aug 1;31(8):2269-2285. doi: 10.1093/ibd/izaf072.
9
Curcumin-QingDai Combination as Treatment for Crohn's Disease: A Case Report.姜黄素-青黛联合治疗克罗恩病：一例报告
Case Rep Gastroenterol. 2025 Jun 11;19(1):423-427. doi: 10.1159/000546012. eCollection 2025 Jan-Dec.
10
From trial data to personalized medicine: a validated framework with an application to Crohn's disease.从试验数据到个性化医疗：一个经验证的框架及其在克罗恩病中的应用
NPJ Digit Med. 2025 May 31;8(1):327. doi: 10.1038/s41746-025-01627-w.

本文引用的文献

1
AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.AGA 技术评论：中重度肠腔和肛旁瘘管型克罗恩病的医学管理
Gastroenterology. 2021 Jun;160(7):2512-2556.e9. doi: 10.1053/j.gastro.2021.04.023.
2
Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.种族和民族对炎症性肠病的诊断和治疗的影响。
Gastroenterology. 2021 Feb;160(3):677-689. doi: 10.1053/j.gastro.2020.08.064. Epub 2020 Oct 21.
3
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial.在抗 TNF 治疗的 IBD 患者临床复发时，即使抗 TNF 药物浓度和抗药抗体检测不到，加用硫唑嘌呤转换方案：一项前瞻性随机试验。
Gut. 2020 Jul;69(7):1206-1212. doi: 10.1136/gutjnl-2019-319758. Epub 2020 Jan 24.
4
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).在 scheduled adalimumab 维持治疗的克罗恩病中停用硫嘌呤：一项前瞻性随机临床试验（DIAMOND2）。
J Gastroenterol. 2019 Oct;54(10):860-870. doi: 10.1007/s00535-019-01582-w. Epub 2019 Apr 30.
5
Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013.1994 年至 2013 年期间英国克罗恩病患者首次和再次手术风险降低。
Clin Gastroenterol Hepatol. 2019 Sep;17(10):2042-2049.e4. doi: 10.1016/j.cgh.2018.12.022. Epub 2018 Dec 21.
6
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.在欧洲基于人群的发病队列中，诊断后 5 年内克罗恩病的自然病程：一项 Epi-IBD 研究。
Gut. 2019 Mar;68(3):423-433. doi: 10.1136/gutjnl-2017-315568. Epub 2018 Jan 23.
7
Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.肛周瘘管性克罗恩病：发病机制、诊断与治疗。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):652-664. doi: 10.1038/nrgastro.2017.104. Epub 2017 Aug 9.
8
American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.美国胃肠病学会关于炎症性肠病治疗药物监测的学会指南。
Gastroenterology. 2017 Sep;153(3):827-834. doi: 10.1053/j.gastro.2017.07.032. Epub 2017 Aug 3.
9
American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.美国胃肠病学会协会治疗药物监测在炎症性肠病管理中的作用技术评论。
Gastroenterology. 2017 Sep;153(3):835-857.e6. doi: 10.1053/j.gastro.2017.07.031. Epub 2017 Jul 31.
10
Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn's disease.布地奈德治疗克罗恩病的药代动力学药物评价
Expert Opin Drug Metab Toxicol. 2017 Jul;13(7):793-801. doi: 10.1080/17425255.2017.1340454. Epub 2017 Jun 16.

AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.

作者信息

Feuerstein Joseph D, Ho Edith Y, Shmidt Eugenia, Singh Harminder, Falck-Ytter Yngve, Sultan Shanaz, Terdiman Jonathan P

机构信息

Division of Gastroenterology and Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, California.

出版信息

Gastroenterology. 2021 Jun;160(7):2496-2508. doi: 10.1053/j.gastro.2021.04.022.

DOI:10.1053/j.gastro.2021.04.022
PMID:34051983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8988893/
Abstract
摘要